Rakesh Radhakrishnan

436 total citations
14 papers, 303 citations indexed

About

Rakesh Radhakrishnan is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Ophthalmology. According to data from OpenAlex, Rakesh Radhakrishnan has authored 14 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 2 papers in Pathology and Forensic Medicine and 2 papers in Ophthalmology. Recurrent topics in Rakesh Radhakrishnan's work include Chromatin Remodeling and Cancer (5 papers), Genomics and Chromatin Dynamics (5 papers) and Epigenetics and DNA Methylation (3 papers). Rakesh Radhakrishnan is often cited by papers focused on Chromatin Remodeling and Cancer (5 papers), Genomics and Chromatin Dynamics (5 papers) and Epigenetics and DNA Methylation (3 papers). Rakesh Radhakrishnan collaborates with scholars based in United States and India. Rakesh Radhakrishnan's co-authors include Renu A. Kowluru, Ghulam Mohammad, Rohini Muthuswami, LeeAnn O. Bailey, Joel W. Hockensmith, Anthony N. Imbalzano, Jeffrey A. Nickerson, Arul J. Duraisamy, Berhane Seyoum and Gary W. Abrams and has published in prestigious journals such as PLoS ONE, Diabetes and Scientific Reports.

In The Last Decade

Rakesh Radhakrishnan

13 papers receiving 301 citations

Peers

Rakesh Radhakrishnan
Siyuan He China
Tyler M. Hudish United States
Amirfarbod Yazdanyar United States
Rakesh Radhakrishnan
Citations per year, relative to Rakesh Radhakrishnan Rakesh Radhakrishnan (= 1×) peers Xiaoting Xi

Countries citing papers authored by Rakesh Radhakrishnan

Since Specialization
Citations

This map shows the geographic impact of Rakesh Radhakrishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rakesh Radhakrishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rakesh Radhakrishnan more than expected).

Fields of papers citing papers by Rakesh Radhakrishnan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rakesh Radhakrishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rakesh Radhakrishnan. The network helps show where Rakesh Radhakrishnan may publish in the future.

Co-authorship network of co-authors of Rakesh Radhakrishnan

This figure shows the co-authorship network connecting the top 25 collaborators of Rakesh Radhakrishnan. A scholar is included among the top collaborators of Rakesh Radhakrishnan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rakesh Radhakrishnan. Rakesh Radhakrishnan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Radhakrishnan, Rakesh, et al.. (2022). On the Interaction Between SMARCAL1 and BRG1. Frontiers in Cell and Developmental Biology. 10. 870815–870815.
3.
Radhakrishnan, Rakesh, et al.. (2021). Altering mammalian transcription networking with ADAADi: An inhibitor of ATP-dependent chromatin remodeling. PLoS ONE. 16(5). e0251354–e0251354. 4 indexed citations
4.
Kowluru, Renu A., Rakesh Radhakrishnan, & Ghulam Mohammad. (2021). Regulation of Rac1 transcription by histone and DNA methylation in diabetic retinopathy. Scientific Reports. 11(1). 14097–14097. 23 indexed citations
5.
Sankar, P., Kumaravel Mohankumar, Rakesh Radhakrishnan, et al.. (2020). Indole Curcumin Reverses Multidrug Resistance by Reducing the Expression of ABCB1 and COX2 in Induced Multidrug Resistant Human Lung Cancer Cells. Letters in Drug Design & Discovery. 17(9). 1146–1154. 11 indexed citations
6.
Kowluru, Renu A. & Rakesh Radhakrishnan. (2020). 574-P: Antioxidant Defence and Long Noncoding RNA in Diabetic Retinopathy. Diabetes. 69(Supplement_1). 1 indexed citations
7.
Radhakrishnan, Rakesh & Renu A. Kowluru. (2020). Long Noncoding RNA MALAT1 and Regulation of the Antioxidant Defense System in Diabetic Retinopathy. Diabetes. 70(1). 227–239. 107 indexed citations
8.
Mohammad, Ghulam, Rakesh Radhakrishnan, & Renu A. Kowluru. (2020). Hydrogen Sulfide: A Potential Therapeutic Target in the Development of Diabetic Retinopathy. Investigative Ophthalmology & Visual Science. 61(14). 35–35. 23 indexed citations
9.
Muthuswami, Rohini, LeeAnn O. Bailey, Rakesh Radhakrishnan, et al.. (2019). BRG1 is a prognostic indicator and a potential therapeutic target for prostate cancer. Journal of Cellular Physiology. 234(9). 15194–15205. 33 indexed citations
10.
Duraisamy, Arul J., Rakesh Radhakrishnan, Berhane Seyoum, Gary W. Abrams, & Renu A. Kowluru. (2019). Epigenetic Modifications in Peripheral Blood as Potential Noninvasive Biomarker of Diabetic Retinopathy. Translational Vision Science & Technology. 8(6). 43–43. 23 indexed citations
11.
Mohammad, Ghulam, Rakesh Radhakrishnan, & Renu A. Kowluru. (2019). Epigenetic Modifications Compromise Mitochondrial DNA Quality Control in the Development of Diabetic Retinopathy. Investigative Ophthalmology & Visual Science. 60(12). 3943–3943. 33 indexed citations
12.
Radhakrishnan, Rakesh, et al.. (2018). Regulation of ATM and ATR by SMARCAL1 and BRG1. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1861(12). 1076–1092. 15 indexed citations
13.
Radhakrishnan, Rakesh, et al.. (2018). RecA-like domain 2 of DNA-dependent ATPase A domain, a SWI2/SNF2 protein, mediates conformational integrity and ATP hydrolysis. Bioscience Reports. 38(3). 6 indexed citations
14.
Radhakrishnan, Rakesh, et al.. (2017). BRG1 and SMARCAL1 transcriptionally co-regulate DROSHA, DGCR8 and DICER in response to doxorubicin-induced DNA damage. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1860(9). 936–951. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026